Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Completed 7Recruiting 5Withdrawn 3Unknown 3Terminated 3Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Kidney Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Pain 1Neoplasm Metastasis 1Mesothelioma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Bone Neoplasms 1Adenocarcinoma 1

Interventions

Paclitaxel 28Trastuzumab 22Cyclophosphamide 21Doxorubicin 14Docetaxel 14Carboplatin 11exemestane 10Radiotherapy 10Letrozole 10Capecitabine 10pembrolizumab 8Lapatinib 8Fulvestrant 8Neoadjuvant Therapy 6Goserelin 6Bevacizumab 6Anastrozole 6pertuzumab 5palbociclib 5eribulin 5abemaciclib 5Therapeutics 5Magnetic Resonance Spectroscopy 5Epirubicin 5Chemotherapy, Adjuvant 5Aromatase Inhibitors 5tucatinib 4Vinorelbine 4Taxes 4Tamoxifen 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Breast Neoplasms × Cryosurgery × Clear all
NCT07439432 2026-02-27

Stereotactic Guided Biopsy and Cryoablation

Montefiore Medical Center

Phase NA Withdrawn
Breast

Breast Neoplasms

NCT02018419 2020-01-22

MBC

Mirror Biologics, Inc.

Phase 1/2 Withdrawn
Breast

Breast Neoplasms

NCT03523299 2019-08-21

Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Withdrawn
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡